🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

With world leaders gathering for the UN High-Level Meeting on Antimicrobial Resistance in New York, BSAC President, andrew seaton, spoke to ITN Business about the urgent need for action on #AMR

"Data is critical to address #AMR. We need to identify what are the priorities. We know the burden is growing significantly. But we don’t yet know how to deliver patient-centred care for AMR." @JenniferCohn2 at the Foreign Policy Health Forum #UNGA79

Speakers at the ⁦United Nations⁩ #AMR panel in agreement about need for more surveillance, One Health surveillance and internationally shared surveillance data. Let’s act.

Excellent to see United Nations endorsement to increase efforts to reduce global antimicrobial resistance un.org/pga/wp-content… webtv.un.org/en/asset/k11/k… Now we need more than the promise, we need national & state-level action #AMR #publichealth #OneHealth

Joint statement on the CDC from the Public Health Association of Australia, Australasian Society for Infectious Diseases, Climate & Health Alliance, & The Royal Australasian College of Physicians: phaa.net.au/Web/Web/News/M… C'mon Australia - let's do this! #ACDC #CDC #PublicHealth PHAA is on Bluesky ASIDANZ Climate and Health Alliance

As a patient, one challenge with #AntimicrobialResistance (#AMR) was understanding what it meant The AMR Narrative has created a short video to explain the basics Subscribe here: youtube.com/watch?v=S_0XQ5… #theAMRnarrative #HealthLiteracy #PatientAdvocacy

“The use of one-time IV antibiotics in the ED did not confer any additional benefits to patients. The use of one-time doses resulted in statistically significant reduced throughput in the ED and statistically significant increased health care costs.” In Journal of the American Pharmacists Association #IDxPosts

✔ Antibacterial pipeline facts: Did you know that of the 128 programmes in clinical development for priority pathogens, only 16 have received marketing authorization? To know more read the 2023 WHO Antibacterial Pipeline analysis: lnkd.in/dU4Gnxb7

The University of South Australia and the Pharmaceutical Society of Australia invited our head of school, Prof Tracy Merlin, to speak at the event. Registration: psa.eventsair.com/psa-events/sag… #PublicHealth #HealthcareSystem

Our open access review of antibacterial candidates with new modes of action is now officially published...now with cover image (thanks to a bit of AI help). Comprehensive analysis of those in clinical development, with an overview of promising preclinical approaches...

"The #AMR pandemic is quiet, but it’s snowballing," @madelinerb2 writes for ASM. asm.org/Articles/2024/…

🔥 📑 A systematic review of antibiotic drug shortages and the strategies employed for managing them ⁦Clinical Microbiology and Infection⁩ funded by ⁦Global Antibiotic R&D Partnership (GARDP)⁩ ⁦Wellcome⁩ In collaboration with 🇮🇳 🇿🇦 🇸🇪 🇬🇧 🇺🇸 colleagues ⁦ clinicalmicrobiologyandinfection.com/article/S1198-…

A Systematic Review of Dental Antibiotic Stewardship Interventions - Teoh - Community Dentistry and Oral Epidemiology - Wiley Online Library onlinelibrary.wiley.com/doi/10.1111/cd…

Proud to see this paper from the lab out today nature showing how rifaximin use is driving dapto-R in VRE. Many years of work, great multi-disciplinary collaborations. Led by Adrianna Turner and Glen Carter Doherty Institute UniMelb MDHS Austin Health rdcu.be/dXUDt

Australian-led study finds that rifaximin (used in liver cirrhosis) can induce daptomycin resistance in VRE. Major clinical consequences as daptomycin is a last-line drug for multidrug-resistant pathogens Nature Medicine Adrianna Turner #AMR #rifaximin nature.com/articles/s4158…

NAAN is thrilled to launch "Adult penicillin allergy programmes in Australian hospitals: a practical guide from the National Antibiotic Allergy Network", a multidisciplinary collaborative effort to aid implementation of #penicillinallergy #AMS programs! onlinelibrary.wiley.com/doi/10.1111/im…

These are the small companies and research groups CARB-X supports at global scale. Not one or two, but dozens at a time. They need both money and scientific, business, and technical help turning ideas into products

Today is One Health Day. The health of humans, animals and ecosystems are closely interlinked. Changes in these relationships can increase the risk of new human and animal diseases developing and spreading. #OneHealth is an approach to optimize the health of humans, animals and

Along with many other fellow AMS/ID colleagues I am making the move to BlueSky. You can find me at: bsky.app/profile/nadine… See you on the other side 🙃

Total antibiotic consumption for countries with available data increased 16.3% btwn 2016-2023, from 29.5 to 34.3 billion defined daily doses (DDDs), and the antibiotic consumption rate across these countries increased 10.6% from 13.7 to 15.2 DDDs per 1,000 inhabitants #AMR